Skip to main navigation Skip to search Skip to main content

LIMT is a novel metastasis inhibiting lncRNA suppressed by EGF and downregulated in aggressive breast cancer

  • Aldema Sas-Chen
  • , Miriam R. Aure
  • , Limor Leibovich
  • , Silvia Carvalho
  • , Yehoshua Enuka
  • , Cindy Körner
  • , Maria Polycarpou-Schwarz
  • , Sara Lavi
  • , Nava Nevo
  • , Yuri Kuznetsov
  • , Justin Yuan
  • , Francisco Azuaje
  • , Igor Ulitsky
  • , Sven Diederichs
  • , Stefan Wiemann
  • , Zohar Yakhini
  • , Vessela N. Kristensen
  • , Anne Lise Børresen-Dale
  • , Yosef Yarden*
  • , Torill Sauer
    • Jürgen Geisler, Solveig Hofvind, Tone F. Bathen, Elin Borgen, Olav Engebråten, Øystein Fodstad, Øystein Garred, Gry Aarum Geitvik, Rolf Kåresen, Bjørn Naume, Gunhild Mari Mælandsmo, Hege G. Russnes, Ellen Schlichting, Therese Sørlie, Ole Christian Lingjærde, Kristine Kleivi Sahlberg, Helle Kristine Skjerven, Britt Fritzman, Oslo Breast Cancer Research Consortium (OSBREAC)
*Corresponding author for this work

Research output: Contribution to journal › Article › Research › peer-review

85 Citations (Scopus)

Fingerprint

Dive into the research topics of 'LIMT is a novel metastasis inhibiting lncRNA suppressed by EGF and downregulated in aggressive breast cancer'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Keyphrases